Abveris to speak at the Future of Drug Discovery and Development Symposium
By Matthew Bartolucci - June 11, 2019
Boston, MA - June 11, 2019 - Ryan Kelly, the Associate Director of Business Development at Abveris, will give a talk about our advanced immunization strategies and antibody discovery platform technologies at the Future of Drug Discovery and Development Symposium hosted by ACROBiosystems and Biocytogen.
The symposium will be held on Thursday June 13, 2019 from 1-6PM in Cambridge.
Join the symposium to learn more about cutting-edge therapeutic antibody discovery technologies and the latest research in biologics drug development. The conference is free to attend, light refreshments and dinner will be provided.
CEO and CSO, Single Cell Technology
CEO, Biocytogen Boston Corp
CSO, LinkedUp Bioscience Inc
Director of In Vivo Pharmacology, Bicycle Therapeutics
Associate Director, BD at Abveris, Co-Founder at AbX Biologics
Associate of Patent and Intellectual Property, Choate, Hall & Stewart LLP